Activation of brown and beige fat can reduce obesity and improve glucose homeostasis through nonshivering thermogenesis. Whether brown or beige fat also secretes paracrine or endocrine factors to promote and amplify adaptive thermogenesis is not fully explored. Here we identify Slit2, a 180 kDa member of the Slit extracellular protein family, as a PRDM16-regulated secreted factor from beige fat cells. In isolated cells and in mice, full-length Slit2 is cleaved to generate several smaller fragments, and we identify an active thermogenic moiety as the C-terminal fragment. This Slit2-C fragment of 50 kDa promotes adipose thermogenesis, augments energy expenditure, and improves glucose homeostasis in vivo. Mechanistically, Slit2 induces a robust activation of PKA signaling, which is required for its prothermogenic activity. Our findings establish a previously unknown peripheral role for Slit2 as a beige fat secreted factor that has therapeutic potential for the treatment of obesity and related metabolic disorders.
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In Brief
Using unbiased proteomics, Svensson et al. identify Slit2 as a protein regulated by Prdm16 and secreted from beige fat cells. Slit2-C, a cleaved C-terminal fragment circulating in plasma, activates a thermogenic, PKA-dependent pathway in adipocytes and improves glucose homeostasis in diet-induced obese mice.
INTRODUCTION
Obesity and obesity-related disorders such as type 2 diabetes are steadily increasing worldwide. Brown fat has attracted significant interest as an antidiabetic tissue owing to its ability to dissipate chemical energy as heat (Lowell and Spiegelman, 2000) . Activation of brown fat thermogenesis involves the induction of a program of genes including uncoupling protein 1 (UCP1), which uncouples respiration from ATP synthesis and increases heat production in fat cells (Kozak and Harper, 2000) . Other, non-UCP1 pathways also appear to contribute to nonshivering thermogenesis (Kazak et al., 2015) . It is now recognized that at least two types of thermogenic fat cells exist: classical interscapular brown fat, located in the interscapular and perirenal regions, and beige fat, which is dispersed among white fat depots Wu et al., 2012) . Brown adipose tissue (BAT) has high basal levels of UCP1, while beige fat has low basal levels that are highly inducible upon stimulation with cold or other agents . Despite their common ability to perform adaptive thermogenesis, brown and beige cells do not derive from the same cell lineage (Lepper and Fan, 2010; Long et al., 2014; Seale et al., 2008) and express different molecular signatures (Long et al., 2014; Sharp et al., 2012; Wu et al., 2012) . Mouse models resistant to weight gain through enhanced brown and beige fat content or activity have demonstrated that activation of thermogenesis in fat can be a powerful strategy to improve metabolic health and prevent weight gain (Cederberg and Enerbä ck, 2003; Fisher et al., 2012; Vegiopoulos et al., 2010; Ye et al., 2012) . Conversely, ablation of UCP1+ cells in transgenic mice causes an increased propensity toward obesity and diabetes (Lowell et al., 1993) . Similarly, UCP1 knockout mice develop obesity under thermoneutral conditions when fed a high-fat diet (Feldmann et al., 2009) .
A key physiological stimulus for inducing active thermogenic fat in mice and humans is cold exposure; this causes release of neurotransmitters such as catecholamines from nerve terminals or M2 macrophages (Morrison et al., 2012; Nguyen et al., 2011) . Brown and beige fat have recently been found to exist in adult humans, as shown by increased glucose uptake in supraclavicular regions upon exposure to cold environment (Cypess et al., 2009; Virtanen et al., 2009; Yoneshiro et al., 2011) . Moreover, human brown fat is also activated by a b3-agonist, illustrating that the canonical cAMP pathway for adipose thermogenesis is likely to be functional in humans . The key characteristics of human BAT have yet to be fully determined, but several studies have shown that supraclavicular human brown fat is most similar to the beige fat of rodents (Sharp et al., 2012; Shinoda et al., 2015; Wu et al., 2012) . Thus, it is believed that human brown and beige fat likely have complementary and overlapping functions in the maintenance of whole-body energy homeostasis.
Previous reports from our group have demonstrated a key function for the transcriptional regulator PRDM16 in the development of both brown and beige fat (Seale et al., 2007 (Seale et al., , 2008 (Seale et al., , 2011 . Mice with a fat-specific ablation of PRDM16 demonstrate significantly lower basal thermogenic gene expression in the subcutaneous fat; these animals are also resistant to browning of the white fat when stimulated with a cold environment or b3-agonist (Cohen et al., 2014) . Conversely, aP2-PRDM16 transgenic mice show enhanced ''browning'' of their subcutaneous adipose depots, leading to augmented energy expenditure, reduced weight gain on high-fat diet, and improved glucose and insulin homeostasis (Seale et al., 2011) .
The various metabolic benefits of activating brown or beige fat have raised great interest in the discovery of hormones and secreted proteins that can act on fat tissue locally or systemically to induce browning. Interestingly, beige fat development occurs in distinct pockets of cells, consistent with the possibility of a paracrine regulatory factor at work. White adipose tissues secrete many proteins factors (adipokines) that influence local and systemic metabolism, including adipsin, adiponectin, leptin, and TNFa (Blü her and Mantzoros, 2015; Rosen and Spiegelman, 2014) . Whether beige adipocytes also secrete factors that can influence the function of fat cells or other organs has not been well studied. We show here that the secreted factor Slit2, a member of the family of Slit homolog proteins, is highly expressed in adipose tissues under the control of PRDM16 and cold exposure. Slits are best known for their role in axon guidance (Brose and Tessier-Lavigne, 2000) and have previously not been described to have any role in adipose tissue. We find that Slit2 is processed proteolytically upon secretion to release a C-terminal protein that is soluble in plasma and has thermogenic effects on fat. These data demonstrate a previously uncharacterized role for a C-terminal protein fragment of Slit2 in adipose tissue homeostasis and glucose metabolism.
RESULTS

Slit2 Is a Factor Secreted from Beige Adipose Cells
To identify factors secreted from beige adipocytes, we used the aP2-PRDM16 transgenic mice as a discovery tool. As reported previously (Seale et al., 2011) , these mice have much more beige fat in vivo, as indicated by the increased number of multilocular, UCP1-positive cells in their inguinal fat pad (iWAT) ( Figure 1A ). Primary cultures of inguinal adipocytes from aP2-PRDM16 mice also show much higher expression of thermogenic genes such as Prdm16, Ucp1, and Cox8. In addition, the previously identified beige and brown markers Eva1, Ear2 , and the beige-enriched mitochondrial marker Gatm (Kazak et al., 2015 ) are elevated at the mRNA level compared to inguinal cultures from wild-type littermates ( Figure 1B ). These data indicate that primary aP2-PRDM16 cultures are enriched in beige adipocytes. On day 6 of differentiation, when cultures were visibly differentiated more than 90%, serum-free conditioned media was collected from aP2-PRDM16 and wild-type inguinal adipocytes. These supernatants were then analyzed by unbiased quantitative proteomics, using the TMT tagging method (see Experimental Procedures). A total of 5,360 proteins were identified in this experiment, of which 1,260 were enriched in aP2-PRDM16 by more than >1.3-fold versus the wild-type adipocytes (Table S1 , available online). We established several criteria for prioritizing these candidates, including the presence of a signal peptide in the annotated gene and regulation by PRDM16 in tissues (see Experimental Procedures and Table  S2 ). This yielded a shorter list of 13 proteins of potential interest ( Figure 1C ). Of these prioritized candidates, two belonged to the same family of Slit homologs of extracellular proteins (Slit2 and Slit3). Multiple peptides from Slit2 and Slit3 were detected in conditioned medium from the beige cells ( Figure S1A ). Brown fat tissues from aP2-PRDM16 fat and adipocyte-specific deletion of PRDM16 also indicated that Slit2 was a factor secreted from thermogenic adipocytes both in vitro and in vivo (Figures S1B and S1C). As described in detail below, our experiments have focused on Slit2.
The Slit family in mice and humans comprises three members: Slit1, Slit2, and Slit3. These are all extracellular matrix proteins of 180-200 kDa with a 29 amino acid signal peptide for classical secretion. They have mainly been studied in the context of brain development Nguyen Ba-Charvet et al., 1999; Wang et al., 1999) . Despite the broad tissue-expression pattern of Slit2 and Slit3, the function of Slit proteins in adult peripheral tissues has not been described. To investigate the function of the Slit members in fat, we first analyzed their expression and regulation in various adipose tissues. Slit2 and Slit3 mRNAs were expressed in all adipose tissues (brown, inguinal, and visceral; Figures S2A and S2B) . Moreover, the mRNA expression of Slit2, but not Slit3, is also inducible in fat by acute, but not long-term, cold exposure in BAT and iWAT ( Figure 1D ). There was a trend to an increase in Slit2 gene expression in iWAT after 3 days of treatment with the b-adrenergic agonist CL316, 243, but this did not reach statistical significance ( Figure S1D ). This might be explained by a rapid-desensitization mechanism upon long-term activation of cAMP, similar to the transient upregulation of Slit2 mRNA seen upon cold exposure ( Figure 1D) . Interestingly, the expression of Slit2 is suppressed in iWAT in diet-induced obese (DIO) mice that also present very low Ucp1 and Adipsin mRNA levels ( Figure 1E ). Slit2 mRNA is also downregulated in epididymal WAT (eWAT) ( Figure 1F ), but not in classical BAT ( Figure S1E ), suggesting distinct mechanisms of transcriptional regulation. In addition, Slit2 is induced in inguinal cells upon stimulation with the cyclic AMP-activator forskolin ( Figure 1G ). These data point to a physiologic regulation of Slit2 in adipose cells and tissues and are suggestive of a link between Slit2 and thermogenic function.
Slit2 Promotes a Thermogenic Program in Cells and in Mice
To assess whether Slit2 promotes thermogenesis in cultured cells, fully differentiated primary inguinal adipocytes were treated with recombinant Slit2 protein (1 mg/ml, 24 hr). Commercial recombinant Slit2 treatment induced an increase of 3-fold in Ucp1 mRNA, as well as large increases in expression of other genes associated with thermogenesis, including Dio2 and Cidea (Figure 2A ). Importantly, recombinant protein treatment using several of the other 13 high-priority candidates (as commercially available recombinant proteins) did not produce a thermogenic response ( Figure 2B ). As a complementary approach for Slit2, we treated primary inguinal adipocytes on day 2 of differentiation with adenoviral vectors expressing full-length Slit2 or LacZ control. Western blotting using an antibody against Slit2 revealed the expression of full-length Slit2 (180 kDa), but also several additional cleavage products, including prominent bands migrating at 50 kDa and 37 kDa ( Figure 2C ). Consistent with the recombinant-protein treatment, ectopic expression of Slit2 robustly induced a thermogenic gene program, with an 8-fold increase in Ucp1 mRNA and 2-to 5-fold elevations in Dio2, Elovl3, and Cidea ( Figure 2D ). To begin to examine whether Slit2 is contributing to physiological browning, we imported floxed Slit2 mice. These animals are on a mixed genetic background and hence are not suitable for metabolic analyses (Rama et al., 2015) . Nevertheless, we generated primary adipocytes from Slit2 flox/flox mice and deleted both the full-length and the cleaved 50 kDa form of Slit2, using adenovirus-mediated Cre expression (Figure 2E) . This resulted in a reduction in thermogenic gene expression and expression of mitochondrial genes in both primary inguinal fat cells and primary brown fat cells (Figures 2F and S3A) . In primary brown fat cells, loss of Slit2 results in reduced oxygen consumption ( Figure S3B ). To understand the molecular relevance of Slit2 in vivo, we used injection of Cre recombinase driven by an AAV vector (AAV-8-CRE) for 3 weeks, which reduced endogenous Slit2 levels in the brown fat by 70%. This resulted in a significant reduction in Ucp1 expression and also reductions in expression of several other mitochondrial genes in this tissue ( Figure 2G ) without any difference in weight loss between the groups ( Figure S3C ). Together these experiments suggest that Slit2 is involved in regulation of thermogenic gene expression in vivo.
To investigate the capacity of pharmacological levels of Slit2 to induce browning in vivo, we expressed either LacZ or Slit2 by intravenous delivery of adenoviral vectors to lean mice. This protocol results in robust expression and secretion of Slit2 from the liver ( Figures 2H and 2I ). Western blotting of the plasma from LacZ-or Slit2-treated mice at 7 days postinjection demonstrated multiple Slit2 fragments secreted into the circulation, including a prominent 50 kDa fragment similar or identical to the 50 kDa band also observed in cultured cells ( Figure 2H ). No changes in lipolysis or lipogenesis gene expression were seen in the liver ( Figure 2I ). In skeletal muscle, no gene expression changes in glucose transporters Glut1 and Glut4 or the inflammatory gene Tnfa were observed ( Figure 2J ). In contrast, and consistent with the in vitro data, circulating Slit2 induced a thermogenic gene-expression program in the iWAT, with a 2.5-fold induction of Ucp1 in iWAT and 1.5-fold induction of Prdm16 ( Figure 2K ). At the same time, white fat selective genes, including Leptin and Resistin, were strongly suppressed by circulating Slit2 ( Figure 2K ). Consistent with the increase in Ucp1 mRNA, iWAT UCP1 protein was also increased, as shown in histological sections stained with an antibody against UCP1 ( Figure 2M ). Circulating Slit2 induced Prdm16 greater than 2-fold in brown fat without any changes in the other thermogenic genes or UCP1 protein; however, the tissue had a more denselooking appearance ( Figures 2L and 2M ). Circulating Slit2 did not change any of the vascular and neuronal markers in fat or in skeletal muscle ( Figures S3D-S3F ). Taken together, these results demonstrate that ectopic-expressed Slit2 in circulation can promote a thermogenic program in cultured adipocytes and adipose tissues.
Identification and Characterization of a Slit2 Cleavage Fragment
The 50 kDa cleavage product observed from full-length Slit2 expression might represent a bioactive fragment of full-length Slit2. We thus sought to characterize this molecule in more detail. Unfortunately, the antibodies commercially available for Slit2 were not effective for immunoaffinity purification of Slit2 from the conditioned media. As an alternative strategy, we generated adenoviruses that express full-length Slit2 with a FLAG tag at the C terminus (Slit2-CTF). Primary inguinal cultures were transduced with Slit2-CTF on day 2, and serum-free conditioned media was collected between days 6 and 7. Western blotting of conditioned media from Slit2-CTF-transduced adipocytes showed secretion of full-length Slit2 (180 kDa), as well as fragments corresponding to 140 kDa and 50 kDa when using an anti-Slit2 antibody ( Figure 3A, left) . Notably, the 50 kDa fragment was also detected by an anti-FLAG antibody, indicating that this band must include the extreme C terminus of Slit2 ( Figure 3A , right). To definitively establish its identity, we next subjected immunoaffinity-purified, FLAG-tagged Slit2-CTF bands to mass spectrometry. Peptides identified from the 50 kDa FLAG-reactive fragment mapped exclusively to the C terminus of Slit2 ( Figure 3B ). In contrast, peptides identified from the full-length 180 kDa band mapped to all portions of the Slit2 protein. Taken together, these results demonstrate that the smaller 50 kDa fragment of Slit2 from fat cells contains the entire C-terminal region of Slit2. The same or a similar cleavage product has been observed previously (Nguyen Ba-Charvet et al., 2001 ) but has no established function.
To examine the activity of the C-terminal fragment (henceforth called Slit2-C), we generated adenoviral constructs encoding Slit2-C, a signal peptide for secretion, and a C-terminal V5-tag ( Figure 3C ). As the N terminus of this C-terminal fragment, we chose the sequence encoding amino acids immediately downstream of the putative cleavage site beginning at TSP (Nguyen Ba-Charvet et al., 2001 ). We also generated a similar construct containing the entire N-terminal portion of Slit2 immediately upstream of the Slit2-C sequence (Slit2-N; Figure 3C ). Primary inguinal adipocytes were transduced with LacZ-, Slit2-N-, and Slit2-C-expressing viruses on day 2, and the cells were harvested on day 6. Both Slit2-N and Slit2-C proteins were efficiently expressed in adipocytes at the predicted molecular sizes: 140 kDa and 50 kDa, respectively ( Figure 3D ). Interestingly, only Slit2-C, but not Slit2-N, was efficiently secreted into the blood following intravenous delivery of adenoviruses into mice ( Figure 3F ), despite efficient hepatic transduction for both constructs ( Figure 3E ). Based on these data, we have focused exclusively on the biological effects of Slit2-C in subsequent experiments in vitro and in vivo.
Slit2-C Is Sufficient to Recapitulate the Thermogenic Activity of Full-Length Slit2
We next sought to determine whether Slit2-C possesses much or any of the thermogenic activity of full-length Slit2. Primary inguinal and brown fat cultures were transduced with the Slit2-C or LacZ control viruses, and thermogenic gene expression was analyzed at day 7. Under these conditions, Slit2-C induced a thermogenic gene expression comparable to full-length Slit2 in primary inguinal cells, while primary brown fat cells responded stronger to Slit2-C ( Figures 4A and 4B) . Next, we injected lean mice with Slit2-C or control adenovirus and analyzed their adipose tissues by gene expression. In the iWAT, Ucp1 mRNA was significantly induced 3-fold, and expression of other mitochondrial genes also showed a modest but significant 1.5-to 2-fold increase ( Figure 4C ). The classical brown fat showed significant changes in the transcriptional regulators Prdm16, Nrf1, and Erra. In addition, there was also an upregulation of expression of several mitochondrial genes such as Atp5b, Uqcrb, Atp6v0d2, Atp9b, and Cox5a, suggestive of an activation of BAT ( Figure 4D ). Similar experiments using 16-week-old DIO mice showed a reduction in Fas in inguinal and brown fat, while Hsl and Atgl were unchanged ( Figures S4A and S4B ). There was also a marked reduction in brown fat levels of Leptin upon Slit2-C treatment, while another white-selective marker, Resistin, was unchanged ( Figure S4C ). Consistent with these gene-expression data, immunohistochemical analysis by UCP1 staining in the inguinal white fat depots showed multiple pockets of UCP1-positive cells in Slit2-C-treated mice compared with control animals ( Figure 4E, upper panel) . In the BAT, UCP1 staining was similar between the two groups; however, the tissue in Slit2-C-treated animals had a more dense-looking appearance with smaller lipid droplets ( Figure 4E, lower panel) . Quantification of Ucp1 protein expression in BAT showed a 1.3-fold induction in BAT in Slit2-Ctreated animals ( Figure S4D ). To assess the physiological effect of Slit2-C expression on tissue respiration, we measured O 2 consumption as the readout. Brown-and white-adipose pads were dissected at day 7 after adenovirus injection, and respiration of minced tissues was measured using a Clark electrode. O 2 consumption was significantly elevated in BAT from mice that received Slit2-C adenovirus versus LacZ control. Qualitatively similar increases were observed in the inguinal pad ( Figure 4F , left), though this only reached significance in the BAT (Figure 4F , right).
Increased Circulating Slit2-C Augments Whole-Body Energy Expenditure and Improves Glucose Homeostasis in Obese Mice
To study the metabolic effects of increased circulating Slit2-C, 16-week-old high-fat diet-fed mice were injected with adenoviral vectors expressing Slit2-C or a LacZ control. Whole-body energy expenditure was analyzed over the following 7 days using a comprehensive laboratory animal monitoring system (CLAMS). Slit2-C induced whole-body oxygen consumption with no difference in respiratory exchange ratio (RER), locomotor activity, food intake ( Figures 5A-5E ), or body weight ( Figure 5G ). The elevated whole-body oxygen consumption in the Slit2-C-treated mice was accompanied by a reduction in the mass of the brown and inguinal, but not epididymal, depots ( Figure 5F ). Importantly, circulating Slit2-C was found to dramatically improve glucose tolerance in DIO mice ( Figure 5H) . Similar experiments performed with full-length Slit2 had comparable results on energy expenditure and glucose tolerance ( Figures S5A-S5F ). Total plasma cholesterol, plasma triglycerides, and nonfasting insulin levels were not affected by Slit2-C treatment (Figures S5G-S5I ). These data demonstrate a new function for the C-terminal fragment of the Slit2 protein in augmenting whole-body energy expenditure and improving certain aspects of metabolic health.
Slit2-C Induces a Thermogenic Program through the PKA Signaling Pathway in Adipocytes
Canonical Slit signaling in the CNS occurs by interaction of the N terminus of Slit proteins with the Robo family of receptors, resulting in signaling through the small GTPase Cdc42 involved in neuronal migration (Wong et al., 2001) . No in vivo function for the circulating C-terminal region of Slit proteins has been described. The Slit2-C fragment as defined here completely lacks this ROBO interaction domain, suggesting that other receptors might be involved in signaling from this protein in adipocytes. To understand the signaling pathways by which Slit2-C exerts its thermogenic effects, we employed phosphoarrays to identify the intracellular signaling pathways activated in primary inguinal adipocytes transduced with Slit2-C versus LacZ adenovirus (see Experimental Procedures). Of the 39 receptor tyrosine kinases and intracellular kinases tested in these initial assays, robust phosphorylation changes were observed in only two proteins, phospho-EGFR and phospho-ERK1/2, together with changes in total EGFR upon Slit2-C overexpression ( Figures  6A and S6A) . However, antagonizing the EGFR and ERK pathways with specific inhibitors failed to reverse the Slit2-C-induced thermogenic gene expression (Figures S6B-S6D ). These data suggest that the EGFR and ERK pathways are (G and H) Body weight (G) and intraperitoneal glucose-tolerance test (H) in 16-week-old DIO mice injected with Slit2-C or LacZ performed at day 7 (n = 9-10). Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. activated by, but not required for, the thermogenic activity of Slit2-C.
We therefore next turned to protein kinase A (PKA) signaling, a pathway known to be involved in the canonical thermogenic activation of fat cells. Slit2-C, but not LacZ, transduced cells showed robust phosphorylation of PKA substrates ( Figure 6B ). Consistent with PKA activation, phosphorylation of hormone-sensitive lipase (HSL S660 ) was induced without changes in total HSL (Figure 6B) . As a comparison, activation of protein kinase C (PKC) substrates and ATGL S406 by Slit2-C was minimal ( Figure 6C ).
Under the same conditions, Slit2-C also increases the protein levels of UCP1, confirming the gene-expression levels upon Slit2-C overexpression ( Figures 6B and 6D ). To exclude potential intracellular effects of adenoviral overexpression, we also generated serum-free conditioned media from cells expressing LacZ, Slit2-FL, or Slit2-C. Treatment of primary inguinal cells with conditioned media also increased PKA signaling in a pattern similar to norepinephrine ( Figure 6E ). These data demonstrate that extracellular Slit2-C activates the canonical b-adrenergic receptor-mediated signaling pathway in adipocytes through an unknown receptor. To more precisely map the mechanism of Slit2-C-induced PKA signaling, we cotreated Slit2-C-transduced adipocytes with various inhibitors. Propranolol, a pan-b-receptor antagonist, did not inhibit Slit2-C-induced thermogenesis ( Figure 6F ), indicating that b-adrenergic signaling is not required for Slit2-C activity. However, an inhibitor of PKA (H89) significantly reduced PKA substrate phosphorylation ( Figure S6E ) and also blunted Slit2-C-induced Ucp1 and Dio2 gene expression ( Figure 6G ). Similar effects were seen using the adenylylcyclase inhibitor SQ-22536, which inhibits the formation of intracellular cAMP ( Figure 6H ). Together these data indicate that the generation of cAMP and activation of PKA signaling are important for the thermogenic activity of Slit2-C.
To provide direct evidence of a cell-surface receptor for Slit2-C, we generated small-scale purified recombinant mammalian Slit2-C from HEK293 cells. The purity and quantification of the protein content (compared with an albumin standard of known concentration) were verified by silver-stained SDS-gel electrophoresis ( Figure 6I ). This shows a 50 kDa band as well as a single FLAG-reactive and Slit2-reactive band on a western blot (Figure 6J) . Importantly, binding of nanomolar concentrations of purified Slit2-C to the cell surface on live adipocytes incubated at 4 C was observed, suggesting the presence of a Slit2-C cell-surface receptor on adipocytes ( Figure 6K ). As a control for specific staining, we performed side-by-side comparisons using another FLAG-tagged protein secreted from thermogenic adipocytes, Pm20D1 (Long et al., 2014) , demonstrating very limited binding to the cell surface of adipocytes compared with Slit2-C (Figure S6F) . Importantly, similarly to the virus-overexpression experiments, a subset of PKA-substrate phosphorylations was increased after Slit2-C protein treatment in a time-dependent ( Figure 6L ) and dose-dependent ( Figure S6G ) manner. In contrast with NE, which induces a full response by 5 min of treatment, Slit2-C induces PKA phosphorylation at a slightly delayed time that peaks around 60 to 90 min ( Figures 6L and S6H) . The purified protein also induces subsequent changes in thermogenic gene expression in both white and brown adipocytes in culture 2 hr after protein treatment ( Figure 6M ). Taken together, these data suggest that Slit2-C is directly inducing the PKA pathway in adipocytes to induce thermogenesis by direct (and likely receptormediated) interaction with the target cell.
DISCUSSION
Human and rodent brown and beige fat have multiple shared characteristics, including a potent b-adrenergic receptor/PKA pathway that activates a thermogenic program. Recent studies in humans subjected to the b3-adrenergic receptor agonist mirabegron demonstrate an increased resting metabolic rate as well as an apparent activation of brown fat ). These observations demonstrate that signaling through the b3-adrenergic receptors, which drive cAMP synthesis, is functional in human BAT in vivo. However, b-adrenergic receptor agonists suffer from untoward effects, limiting their clinical use for the treatment of obesity and diabetes.
Here, we report that the C-terminal fragment of Slit2, which is produced endogenously by adipose cells, has several properties that make it of potential translational interest. First, Slit2 expression is under the control of PRDM16, an important regulator of both brown and beige fat in rodents. PRDM16 is also selectively expressed in human brown fat cells and tissues (Jespersen et al., 2013; Shinoda et al., 2015) . Second, and importantly, the Slit2 C-terminal fragment appears to function largely through the cAMP/PKA-signaling system. Although the magnitude of induction may be lower and delayed in time compared with direct b-adrenergic receptor activation, it has the advantage of not working through the widely distributed b-adrenergic receptors. It is thus expected that this molecule may circumvent some or all of the existing side effects of direct b-adrenergic receptor agonism, though possible side effects of the Slit2-C system will have to be determined.
The transcriptional regulation of Slit2 suggests that cold exposure may control its expression in a manner not completely dependent on the b-adrenergic systems in iWAT and BAT. In Figure 6F , we showed that the mechanism of transcriptional regulation of Ucp1 is somewhat independent of the adrenergic receptors; hence, a parallel pathway of regulation may exist. Furthermore, Slit2 mRNA is reduced in iWAT after high-fat diet. We see similar reductions of Slit2 mRNA in eWAT, but not in BAT, in mice fed a high-fat diet, pointing toward interesting and distinct regulation mechanisms in the different adipose depots.
This study also reveals a functional specificity of Slit2 C-terminal fragment that is distinct from previous studies of Slit2. In brain, the actions of Slit2 are principally thought to occur via its N-terminal ROBO-binding domain Wang et al., 1999 ). Here we demonstrate that Slit2-C, which does not contain this ROBO-binding motif, nevertheless possesses potent antidiabetic effect in vivo. These data demonstrate that the biological effects of Slit2 extend well beyond its ROBO-binding activity and N-terminal domain. It is worth considering that Slit2-C may also be important in other areas of physiology. Even this 50 kDa Slit2-C fragment has multiple domains, and we do not rule out the possibility that it might activate other pathways. BAT and iWAT respond slightly differently to Slit2-C overexpression in terms of downstream transcriptional targets. This might have many explanations, such as differences in baseline levels of thermogenic genes, the presence and abundance of the receptor(s) or coreceptor(s), and also the fact that there are preferential signaling pathways in BAT and iWAT induced upon stimulation. We find that the PKA signaling is one mechanism that at least in part is responsible for the thermogenic effects. Studies evaluating the physiological relevance of circulating Slit2 in plasma are important for its significance as an endogenous endocrine protein. To date, because of lack of specific reagents for the detection of Slit2 protein in plasma, we have no absolute quantifications of the circulating levels. However, multiple unique peptides of Slit2 from both the N-and C-terminal Slit2 have been found in an independent plasma-proteomic study (Liu et al., 2007) . Together with the findings in this paper, we have evidence that the 50 kDa fragment of Slit2 may function, at least in part, in an endocrine fashion.
Taken together, we show here that the Slit2-C pathway may be promising for the treatment of obesity and related metabolic disorders. Moving forward, the identification of the protease that generates Slit2-C from full-length Slit2, as well as the functioning Slit2-C receptors, would allow elucidation of additional aspects of the Slit2-C-signaling pathway in adipocytes. Further engineering of the Slit2 molecule may reveal endogenous or synthetic fragments optimized as therapeutic agents and/or as tools to probe human brown fat biology.
EXPERIMENTAL PROCEDURES Animals
All animal experiments were approved by the Institutional Animal Care and Use Committee of the Beth Israel Deaconess Medical Center. Male mice (Mus musculus, C57/b6 or Balb/c when indicated) were obtained from Jackson Laboratories, maintained in 12 h light-dark cycles (6 a.m.-6 p.m.) at 22 C, and fed a standard irradiated rodent chow diet or a high-fat diet (60% fat) for 12-20 weeks. AAV-8 viruses (Penn Vector Core) and adenoviruses (Vector Biolabs or constructed in house) were injected at a titer of 10 11 or 10 10 per mouse, respectively.
The aP2-Prdm16-transgenic mice have been previously described (Seale et al., 2011) . Prdm16-floxed mice were crossed with adiponectin-Cre and were maintained on a pure C57BL/6 background (Cohen et al., 2014) . The Slit2-floxed mice have been described previously (Rama et al., 2015) .
Metabolic Phenotyping
Glucose tolerance test was performed on mice with no difference in weight at 7 days postinjection with adenovirus. Animals were fasted overnight and then received intraperitoneal glucose at 1 mg/kg. Energy expenditure was analyzed using a CLAMS (Columbus Instruments). Cold-exposure and thermoneutral experiments were performed in Balb/c mice at 4 C or 30 C, respectively. Total levels of cholesterol, free fatty acids, triglycerides, and insulin were measured at the Core Facility at Joslin Diabetes Center.
Respiration
Tissue respiration was performed using a Clark electrode (Stathkelvin Instruments). Freshly isolated tissues were dissected from mice treated with adenovirus for 7 days. Equally sized pieces of tissue were minced and placed in respiration buffer containing PBS supplemented with 2% (w/v) bovine serum albumin, 1% (w/v) glucose, and 1 mM Na pyruvate. O 2 consumption was normalized to tissue wet weight. Cellular oxygen consumption rates were determined using an XF24 Extracellular Flux Analyzer (Seahorse Biosciences). Detailed experimental procedures can be found in the Supplemental Experimental Procedures.
Primary White and Brown Adipocyte Cultures
Inguinal and brown stromal-vascular fractions were obtained from 6-week-old male or newborn mice (post-natal days 5-10) for white-and brown fat cultures, respectively. Detailed experimental procedures can be found in the Supplemental Experimental Procedures.
Molecular Studies
RNA was extracted from cultured cells or frozen tissue samples using TRIzol and purified with QIAGEN RNeasy minicolumns. Normalized RNA was reverse transcribed using a high-capacity cDNA reverse-transcription lot (Applied Biosystems), and cDNA was analyzed by qRT-PCR. Relative mRNA levels were calculated using the comparative CT method and normalized to cyclophilin mRNA. All primers used are listed with their sequences in Table S3 . For western blotting, homogenized tissues, whole-cell lysates, or concentrated serum-free conditioned medium were lysed in RIPA buffer containing protease-inhibitor cocktail (Thermo Scientific) and phosphatase-inhibitor cocktail (Thermo Scientific), separated by SDS-PAGE, and transferred to ImmobilonP membranes (Millipore). For western blotting of plasma samples, 1 ml plasma was prepared containing 23 sample buffer (Invitrogen) with reducing agent, boiled, and analyzed using western blot against V5, FLAG, or indicated antibody. V5-antibody was from Life Technologies, and anti-Flag M2-HRP (A8592) from Sigma Aldrich. Antibody for Slit2 (ab134166) was from abcam. Phospho-PKA substrate, phospho-PKC substrate, phospho-ERK1/2, total ERK, phospho-AKT, total AKT, phospho-AMPK, total AMPK, phospho-ATGL, ATGL, phospho-EGFR, and EGFR were from Cell Signaling. Protein array was from R&D Systems (Proteome Profiler Mouse Phospho-RTK Array Kit, ARY014). Silver stain (SilverQuest Silver Staining Kit, LC6070) was purchased from Thermo Fisher.
Immunohistochemistry
Tissues were fixed in 4% paraformaldehyde. Paraffin embedding and sectioning were done by the Dana-Farber/Harvard Cancer Center Research Figure 6 . Slit2-C Induces a Thermogenesis Program through the PKA Signaling Pathway in Adipocytes Pathology core facility. For UCP1 immunohistochemistry, slides were deparaffinized in xylene; hydrated in 95%, 80%, and 70% ethanol; and rinsed in water before heat-mediated antigen retrieval in 10 mM (pH 6.0) sodium-citrate buffer. Quenching of endogenous peroxidases was performed using peroxidasequenching solution (Invitrogen). Slides were blocked in 10% goat serum and incubated with rabbit polyclonal UCP1 antibody (abcam, ab10983) at 2 mg/ml in PBS-T/1% BSA overnight at 4 C. Slides were washed in PBS-T and incubated with 1:500 donkey anti-rabbit IgG HRP-linked antibody (GE Healthcare) before developing using SuperPicture 3rd Gen IHC Detection Kit (Invitrogen). Hematoxylin was used as counterstain. Immunohistochemical stainings of different fat depots were observed with a Nikon 80i upright light microscope using a 103 objective lens. Digital images were captured with a Nikon Digital Sight DS-Fi1 color camera and NIS-Elements acquisition software.
Construction of the Slit2 Adenoviral Expression Plasmid, Viral Packaging, Transduction, and Slit2-N and Slit2-C Expression Expression of Slit2-N and Slit2-C was performed by amplification from mouse Slit2 cDNA and ligated into the pENTR dual-selection vector with a signalpeptide sequence. For detailed methods, see Supplemental Experimental Procedures.
Cloning and Purification of Mammalian Recombinant Slit2-C
The pENTR/D-TOPO-Slit2-C was shuttled with LR Clonase (Thermo Fisher Scientific) into an in-house-generated, gateway-compatible variant of pCLHCX-DEST. Protein was purified from mammalian cell-culture medium. Detailed experimental procedures can be found in the Supplemental Experimental Procedures.
Cell-Surface Staining of Slit2-C Using Confocal Laser-Scanning Microscopy Live, primary differentiated adipocytes were incubated with recombinant Slit2-C FLAG-tagged protein for 1 hr at 4 C before fixation and staining with a fluorescent antibody for visualization of cell-surface-bound proteins using a confocal laser-scanning microscope. For detailed methods, see Supplemental Experimental Procedures.
Mass Spectrometry Analysis
Secreted proteins from primary inguinal cells from wild-type or ap2-PRDM16 mice were concentrated by methanol chloroform precipitation and analyzed by mass spectrometry analysis. Immunoprecipitation of Slit2-FLAG was performed using conditioned serum-free medium from primary inguinal cells expressing Slit2-FL-FLAG using anti-FLAG M2 magnetic beads (Sigma Aldrich). Mass spectrometry for the detection of FLAG-reactive bands was performed by in-gel digestion of immunopurified Slit2-CTF separated on SDS-page and stained with SimplyBlue SafeStain (Invitrogen). Detailed experimental procedures can be found in the Supplemental Experimental Procedures.
Statistical Analysis
All values in graphs are presented as mean ± SEM. Student's t test was used for single comparisons. Two-way ANOVA with repeated measures was used for the GTT studies. The error bars (SEM) shown for all results were derived from biological replicates, not technical replicates. Significant differences between two groups (*p > 0.05, **p > 0.01, ***p > 0.001) were evaluated using a two-tailed unpaired t test as the sample groups displayed a normal distribution and comparable variance. 
